HIGHLIGHTS
- who: Bernard Maillu00e8re from the Universitu00e9 Paris-Saclay, CEA, INRAE, Du00e9partement Mu00e9dicaments et Technologies pour la Santu00e9, SIMoS, Gif-sur-Yvette, France University of Basel, Switzerland have published the paper: Specificity of the T Cell Response to Protein Biopharmaceuticals, in the Journal: (JOURNAL)
- what: The aim of this paper is to review recent developments in the understanding the T_cell response to BPs, with a main focus on mechanisms controlling peptide specificity, T_cell selection and regulation.
- future: Investigations are required to generalize these observations to other anti-TNF therapeutic antibodies or other BPs. Studies . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.